• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Estimated glomerular filtration rate reversal by blood pressure lowering in chronic kidney disease: Japan Multicenter Investigation for Cardiovascular DiseaseB CKD study.降压对慢性肾脏病患者估计肾小球滤过率的逆转作用:日本心血管疾病多中心慢性肾脏病研究。
J Clin Hypertens (Greenwich). 2013 Mar;15(3):171-5. doi: 10.1111/jch.12054. Epub 2012 Dec 14.
2
Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease.阿利吉仑对慢性肾病高血压患者肾脏保护作用的疗效分析
Heart Vessels. 2013 Jul;28(4):442-52. doi: 10.1007/s00380-012-0260-7. Epub 2012 May 23.
3
An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone.血管紧张素 II 受体阻滞剂-钙通道阻滞剂联合治疗比高剂量血管紧张素 II 受体阻滞剂单独治疗能更好地预防老年高危高血压合并慢性肾脏病患者的心血管事件。
Kidney Int. 2013 Jan;83(1):167-76. doi: 10.1038/ki.2012.326. Epub 2012 Oct 10.
4
Prevalence and risk factors of chronic kidney disease in newly diagnosed and untreated hypertensive patients in cameroon: A cross-sectional study.喀麦隆新诊断且未治疗的高血压患者慢性肾脏病的患病率及危险因素:一项横断面研究
Saudi J Kidney Dis Transpl. 2017 Sep-Oct;28(5):1144-1149. doi: 10.4103/1319-2442.215143.
5
Seasonal variation in estimated glomerular filtration rate based on serum creatinine levels in hypertensive patients.高血压患者基于血清肌酐水平估算的肾小球滤过率的季节性变化。
Tohoku J Exp Med. 2011 Jun;224(2):137-42. doi: 10.1620/tjem.224.137.
6
Effect of renal function on antihypertensive drug safety and efficacy in children.肾功能对儿童降压药安全性和疗效的影响。
Pediatr Nephrol. 2018 Jan;33(1):139-146. doi: 10.1007/s00467-017-3763-8. Epub 2017 Aug 4.
7
CKD awareness and blood pressure control in the primary care hypertensive population.在基层医疗机构的高血压患者中提高对慢性肾脏病的认识和血压控制水平。
Am J Kidney Dis. 2011 Jan;57(1):71-7. doi: 10.1053/j.ajkd.2010.08.022. Epub 2010 Nov 17.
8
Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study.慢性肾脏病患者药物依从性与临床结局之间的关联:一项前瞻性队列研究。
Clin Exp Nephrol. 2017 Jun;21(3):504-512. doi: 10.1007/s10157-016-1312-6. Epub 2016 Jul 20.
9
Hypertension control and antihypertensive therapy in patients with chronic kidney disease.慢性肾脏病患者的高血压控制与抗高血压治疗
Am J Hypertens. 2015 Jun;28(6):814-22. doi: 10.1093/ajh/hpu215. Epub 2014 Nov 24.
10
Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan.氯沙坦治疗的高血压患者血尿酸对肾功能和心血管事件的影响。
Hypertens Res. 2012 Aug;35(8):867-73. doi: 10.1038/hr.2012.59. Epub 2012 May 10.

引用本文的文献

1
Clinical and pathological analysis of the kidney in patients with hypertensive nephropathy.高血压肾病患者肾脏的临床与病理分析
Exp Ther Med. 2013 Nov;6(5):1243-1246. doi: 10.3892/etm.2013.1306. Epub 2013 Sep 18.

本文引用的文献

1
Kidney function can improve in patients with hypertensive CKD.高血压性慢性肾脏病患者的肾功能可得到改善。
J Am Soc Nephrol. 2012 Apr;23(4):706-13. doi: 10.1681/ASN.2011050456. Epub 2012 Mar 8.
2
Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease.高血压合并冠心病患者的降压治疗可实现心脏逆重构和心功能改善。
J Hypertens. 2010 Jan;28(1):178-85. doi: 10.1097/HJH.0b013e3283324668.
3
Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).阿托伐他汀对糖尿病患者肾脏结局和心血管疾病的影响:来自阿托伐他汀糖尿病协作研究(CARDS)的分析
Am J Kidney Dis. 2009 Nov;54(5):810-9. doi: 10.1053/j.ajkd.2009.03.022. Epub 2009 Jun 21.
4
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study.阿托伐他汀强化降脂对冠心病患者肾功能的影响:达标新治疗(TNT)研究
Clin J Am Soc Nephrol. 2007 Nov;2(6):1131-9. doi: 10.2215/CJN.04371206. Epub 2007 Oct 17.
5
Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy).硝苯地平缓释片在既往有心肌梗死的日本高血压患者中预防心绞痛住院方面优于血管紧张素转换酶抑制剂(JMIC - B子研究)。
J Hypertens. 2007 Oct;25(10):2019-26. doi: 10.1097/HJH.0b013e32829c6908.
6
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.在肾脏病饮食改良研究方程中使用标准化血清肌酐值来估算肾小球滤过率。
Ann Intern Med. 2006 Aug 15;145(4):247-54. doi: 10.7326/0003-4819-145-4-200608150-00004.
7
Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.血管紧张素转换酶抑制剂治疗对慢性稳定型冠心病患者肾功能及疗效的影响:预防事件用ACE抑制剂(PEACE)试验
Circulation. 2006 Jul 4;114(1):26-31. doi: 10.1161/CIRCULATIONAHA.105.592733. Epub 2006 Jun 26.
8
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).肾性骨营养不良的定义、评估及分类:改善全球肾脏病预后组织(KDIGO)的立场声明
Kidney Int. 2006 Jun;69(11):1945-53. doi: 10.1038/sj.ki.5000414.
9
Quantitative coronary angiogram analysis: nifedipine retard versus angiotensin-converting enzyme inhibitors (JMIC-B side arm study).冠状动脉造影定量分析:缓释硝苯地平与血管紧张素转换酶抑制剂(JMIC-B 分侧研究)
Hypertension. 2005 Jun;45(6):1153-8. doi: 10.1161/01.HYP.0000165677.71421.8c. Epub 2005 Apr 25.
10
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.慢性肾脏病与死亡、心血管事件及住院风险
N Engl J Med. 2004 Sep 23;351(13):1296-305. doi: 10.1056/NEJMoa041031.

降压对慢性肾脏病患者估计肾小球滤过率的逆转作用:日本心血管疾病多中心慢性肾脏病研究。

Estimated glomerular filtration rate reversal by blood pressure lowering in chronic kidney disease: Japan Multicenter Investigation for Cardiovascular DiseaseB CKD study.

机构信息

Kyoto University Hospital, Kyoto, Japan.

出版信息

J Clin Hypertens (Greenwich). 2013 Mar;15(3):171-5. doi: 10.1111/jch.12054. Epub 2012 Dec 14.

DOI:10.1111/jch.12054
PMID:23458588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8033949/
Abstract

Patients are diagnosed as having chronic kidney disease (CKD) if estimated glomerular filtration rate (eGFR) is <60 mL/min/1.73 m(2) . Low eGFR is likely to increase the incidence of cardiovascular events and lead to dialysis. Therefore, it is important to prevent eGFR from decreasing eGFR. However, it still remains unknown whether antihypertensive therapy can prevent low eGFR from becoming even lower and improve eGFR in hypertensive patients with CKD. The authors analyzed the results of the Japan Multicenter Investigation for Cardiovascular DiseaseB (JMIC-B) and investigated the effects of antihypertensive therapy on eGFR. In hypertensive patients with CKD (eGFR <60), eGFR was significantly increased from 51.87±6.21 (n=98) to 57.55±19.00 (P<.001) after 3 years of antihypertensive therapy. In patients without CKD (eGFR ≥60), eGFR was significantly decreased from 91.84±23.27 (n=682) to 88.95±23.67 (P<.001). Regardless of the type of antihypertensive drugs used, eGFR was significantly increased in patients with CKD and was significantly decreased in patients without CKD. This paper shows that antihypertensive therapy can improve eGFR in hypertensive patients with CKD. J Clin Hypertens (Greenwich). 2012;00:00-00. ©2012 Wiley Periodicals, Inc.

摘要

如果估算肾小球滤过率(eGFR)<60 mL/min/1.73 m(2),则将患者诊断为患有慢性肾脏病(CKD)。低 eGFR 可能会增加心血管事件的发生率,并导致透析。因此,防止 eGFR 下降非常重要。然而,目前仍不清楚降压治疗是否可以防止低 eGFR 进一步降低,并改善 CKD 高血压患者的 eGFR。作者分析了日本多中心心血管疾病研究(JMIC-B)的结果,并研究了降压治疗对 eGFR 的影响。在 CKD(eGFR <60)的高血压患者中,经过 3 年的降压治疗,eGFR 从 51.87±6.21(n=98)显著增加到 57.55±19.00(P<.001)。在无 CKD(eGFR ≥60)的患者中,eGFR 从 91.84±23.27(n=682)显著下降到 88.95±23.67(P<.001)。无论使用何种类型的降压药物,CKD 患者的 eGFR 均显著升高,而无 CKD 患者的 eGFR 则显著降低。本文表明,降压治疗可改善 CKD 高血压患者的 eGFR。J Clin Hypertens (Greenwich). 2012;00:00-00. ©2012 Wiley Periodicals, Inc.